Anavex Life Sciences Corp (AVXL)

[RedShoulder]

Why is not potential revenue calculations being made on more than 342,000 Australians that are living with dementia? A number expected to increase to 400,000 in less than a decade.

I lived with AD in my family, I know how hard it is on the patients and care givers. I can say with a great deal of certainty and logic, that all AD suffers (and their caregivers) will want be on 2-73. How fast the roll out is the only question.

IMO, most of the 342,000 Alzheimer suffers will opt for the medication. That is a lot of revenue potential coming Anavex's way, and no sharing the revenues.

I'll start this calculations by asking a guesstament of what a daily treatment would cost in pills?